Primary analysis of MOUNTAINEER: A phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC Meeting Abstract
| Authors: | Strickler, J.; Cercek, A.; Siena, S.; André, T.; Ng, K.; Van Cutsem, E.; Wu, C.; Paulson, A.; Hubbard, J.; Coveler, A.; Fountzilas, C.; Kardosh, A.; Kasi, P.; Lenz, H.; Ciombor, K.; Elez, E.; Bajor, D.; Stecher, M.; Feng, W.; Bekaii-Saab, T. |
| Abstract Title: | Primary analysis of MOUNTAINEER: A phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC |
| Meeting Title: | ESMO 24th World Congress on Gastrointestinal Cancer 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2022 Jun 29-Jul 2 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-06-01 |
| Start Page: | S375 |
| End Page: | S376 |
| Language: | English |
| ACCESSION: | WOS:000823826500360 |
| DOI: | 10.1016/j.annonc.2022.04.440 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA-2 -- Source: Wos |
